CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
EASL 2015   Banner2   HighwayRx
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Gilead patents on costly hepatitis C drug challenged in 5 countries
05-20-2015
Novo Nordisk weighs diabetes drug's use in fatty liver disease
05-18-2015
Pricey new hepatitis C drugs could yield economic benefits
05-18-2015
Some cancer patients need hepatitis B virus screening before therapy
05-15-2015
View Complete News Library
 
 
July 8-11
21ST ANNUAL INTERNATIONAL CONGRESS OF THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY (ILTS)
CHICAGO, IL
September 4-6
9th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Paris, France
October 16-21
ACG 2015 Annual Scientific Meeting and Postgraduate Course
Honolulu, Hawaii
November 13-17
AASLD 2015
San Francisco, CA
View all Congresses
 
HighwayRx
 
 
 
  Line  
  Featured Abstracts          
 
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients with Advanced Liver Disease
 
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis
 
Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection
 
Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hcv genotype 1 infection: Analysis of phase 3 ION trials
 
Sorting out cirrhosis: Mechanisms of non-response to hepatitis C therapy
 
Interferon-free therapy for hepatitis C: The hurdles amid a golden era
 
 
Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir
 
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
 
High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia
 
Screening for human immunodeficiency virus and other sexually transmitted diseases among u.s. Women with prenatal care
 
Cognitive dysfunction and hepatitis C virus infection
 
The etiology of cirrhosis is a strong determinant of brain reserve: A multi-modal MR imaging study
 
 
Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis
 
Covert hepatic encephalopathy: does the mini-mental state examination help?
 
Current Trends and Recent Advances in Diagnosis, Therapy, and Prevention of Hepatocellular Carcinoma
 
Systematic Review of Catheter-Based Intraarterial Therapies in Hepatocellular Carcinoma: State of the Art and Future Directions
 
I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis
 
Biphenotypic hepatic tumors: imaging findings and review of literature
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.